Combining CD40 agonist mitazalimab with mFOLFIRINOX in previously untreated metastatic pancreatic ductal adenocarcinoma (OPTIMIZE-1): a single-arm, multicentre phase 1b/2 study
Titel:
Combining CD40 agonist mitazalimab with mFOLFIRINOX in previously untreated metastatic pancreatic ductal adenocarcinoma (OPTIMIZE-1): a single-arm, multicentre phase 1b/2 study
Auteur:
Van Laethem, Jean-Luc Borbath, Ivan Prenen, Hans Geboes, Karen Paula Lambert, Aurélien Mitry, Emmanuel Cassier, Philippe Alexandre Blanc, Jean-Frédéric Pilla, Lorenzo Batlle, Jaime Feliu Garrote, Mercedes Rodriguez Pazo-Cid, Roberto Antonio Gallego, Inmaculada Smith, Karin Enell Ellmark, Peter Pico de Coaña, Yago Ambarkhane, Sumeet Vijay Macarulla, Teresa